Natera, Inc. (NTRA): Free Cash Flow
$109.11M
Year ended 2025-12-31
$84.20M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $109.11M | +57.6% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $69.24M | n/m | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | -$286.15M | n/m | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | -$479.20M | n/m | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | -$376.27M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$202.12M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | -$68.41M | n/m | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | -$74.46M | n/m | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | -$107.69M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | -$97.19M | n/m | 2019-03-15, From 2016-01-01 |
| 2015-12-31 | -$45.68M | n/m | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | $533.0K | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$32.38M | n/a | 2016-03-24, From 2013-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Natera, Inc. (NTRA) | 2025-12-31 | $109.11M | +57.6% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $88.30M | -62.8% |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$233.07M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $66.89M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $126.63M | +98.5% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $1.36B | +49.5% |
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $1.21B | +10.0% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $28.33M | -22.5% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | -$124.21M | n/m |
Compare NTRA, FTRE, GH, CAI side by side · Screen every company in Services-Medical Laboratories ↗